"...Drugs That Work In Mice Often Fail When Tried In People
Most potential new drugs fail when they're tested in people. These failures are not only a major disappointment, they sharply drive up the cost of developing new drugs.
A major reason for these failures is that most new drugs are first tested out in mice, rats or other animals. Often those animal studies show great promise.
But mice aren't simply furry little people, so these studies often lead science astray.
Some scientists are now rethinking animal studies to make them more effective for human health. When scientists first started using animals in research over a century ago, the animals were not regarded as human stand-ins. Scientists studying rats were initially trying to understand rats..."
https://www.npr.org/sections/health-shots/2017/04/10/522775456/drugs-that-work-in-mice-often-fail-when-tried-in-people
- Forums
- ASX - By Stock
- NOX
- Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed
Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-14
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.0¢ | $9.409K | 87.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49737 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 51289 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49737 | 0.105 |
4 | 44611 | 0.100 |
1 | 50354 | 0.099 |
1 | 20000 | 0.098 |
1 | 6000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 51289 | 1 |
0.120 | 163382 | 5 |
0.125 | 164133 | 6 |
0.130 | 409378 | 5 |
0.135 | 200000 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |